NF1 and cancer: Examination of genomic data from the Cancer Cell Line Encyclopedia (CCLE) and TCGA has indicated that whilst canonical KRAS mutations do not occur with increased frequency in the context of NF1 mutations, non-canonical KRAS mutations certainly do, suggesting that such pairs of mutations might act together to confer a selective advantage in human tumours [164].